Alizé Pharma acquires rights on a new peptide for bone diseases

Mathim_actu
Mathym launches its process scale-up phase
16 January 2015
AlizeePharma_actu
Alizé Pharma raises another € 5 m
10 September 2014

Alizé Pharma acquires rights on a new peptide for bone diseases

AlizeePharma_actu

The project will be developed by the Newco, Alizé Pharma III.